Francesca Iommelli

739 total citations
29 papers, 505 citations indexed

About

Francesca Iommelli is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Francesca Iommelli has authored 29 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Francesca Iommelli's work include Lung Cancer Treatments and Mutations (9 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cell Adhesion Molecules Research (5 papers). Francesca Iommelli is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Cancer, Hypoxia, and Metabolism (6 papers) and Cell Adhesion Molecules Research (5 papers). Francesca Iommelli collaborates with scholars based in Italy, United States and Spain. Francesca Iommelli's co-authors include Silvana Del Vecchio, Viviana De Rosa, Rosa Fonti, M. Monti, Maria Patrizia Stoppelli, Giuseppina Votta, Marco Salvatore, Antonella Zannetti, Rosa Camerlingo and Giovanni Di Minno and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Francesca Iommelli

28 papers receiving 503 citations

Peers

Francesca Iommelli
Pranshu Sahgal Finland
Aaron M. LeBeau United States
Steven King United States
Kerstin Schlüter Germany
Carmine Fedele United States
Heike Zieher Germany
Jun Niu China
Miran Rada Canada
Robert Seed United Kingdom
Gian Carlo Alghisi Switzerland
Pranshu Sahgal Finland
Francesca Iommelli
Citations per year, relative to Francesca Iommelli Francesca Iommelli (= 1×) peers Pranshu Sahgal

Countries citing papers authored by Francesca Iommelli

Since Specialization
Citations

This map shows the geographic impact of Francesca Iommelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Iommelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Iommelli more than expected).

Fields of papers citing papers by Francesca Iommelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Iommelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Iommelli. The network helps show where Francesca Iommelli may publish in the future.

Co-authorship network of co-authors of Francesca Iommelli

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Iommelli. A scholar is included among the top collaborators of Francesca Iommelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Iommelli. Francesca Iommelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Franzese, Adriana, et al.. (2025). Neutrophil extracellular traps as drivers of epithelial-mesenchymal transition in cancer cells. Frontiers in Immunology. 16. 1655019–1655019. 1 indexed citations
2.
Rosa, Viviana De, Caterina De Rosa, Daniela Omodei, et al.. (2025). Effect of IL-1β on NSCLC-Derived Small Extracellular Vesicles as Actors in Mediating Cancer Progression and Evading Immune System. International Journal of Molecular Sciences. 26(14). 6825–6825.
3.
Rosa, Caterina De, Concetta Tuccillo, Viviana De Rosa, et al.. (2025). Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients. Cell Death and Disease. 16(1). 286–286. 3 indexed citations
4.
Omodei, Daniela, Caterina De Rosa, Roberta Buono, et al.. (2024). Combined Therapeutic Strategies Based on the Inhibition of Non-Oncogene Addiction to Improve Tumor Response in EGFR- and KRAS-Mutant Non-Small-Cell Lung Cancer. Cancers. 16(23). 3941–3941. 1 indexed citations
5.
Iommelli, Francesca, Natalia Di Pietro, Maria Cristina Curia, et al.. (2024). Exosome-like Systems: From Therapies to Vaccination for Cancer Treatment and Prevention—Exploring the State of the Art. Vaccines. 12(5). 519–519. 9 indexed citations
6.
Rosa, Caterina De, Viviana De Rosa, Concetta Tuccillo, et al.. (2024). ITGB1 and DDR activation as novel mediators in acquired resistance to osimertinib and MEK inhibitors in EGFR-mutant NSCLC. Scientific Reports. 14(1). 500–500. 9 indexed citations
7.
Rosa, Caterina De, Viviana De Rosa, Paola Franco, et al.. (2024). Immune-Cell-Derived Exosomes as a Potential Novel Tool to Investigate Immune Responsiveness in SCLC Patients: A Proof-of-Concept Study. Cancers. 16(18). 3151–3151. 4 indexed citations
8.
Altobelli, Giovanna Giuseppina, et al.. (2024). Dynamic roles of neutrophil extracellular traps in cancer cell adhesion and activation of Notch 1-mediated epithelial-to-mesenchymal transition in EGFR-driven lung cancer cells. Frontiers in Immunology. 15. 1470620–1470620. 6 indexed citations
9.
Rosa, Viviana De, Francesca Iommelli, Antonio Pezone, et al.. (2023). ATM inhibition blocks glucose metabolism and amplifies the sensitivity of resistant lung cancer cell lines to oncogene driver inhibitors. SHILAP Revista de lepidopterología. 11(1). 20–20. 9 indexed citations
10.
Belli, Stefania, Paola Franco, Francesca Iommelli, et al.. (2020). Breast Tumor Cell Invasion and Pro-Invasive Activity of Cancer-Associated Fibroblasts Co-Targeted by Novel Urokinase-Derived Decapeptides. Cancers. 12(9). 2404–2404. 6 indexed citations
11.
Rosa, Viviana De, et al.. (2020). Preclinical imaging for targeting cancer immune evasion. The Quarterly Journal of Nuclear Medicine and Molecular Imaging. 64(2). 186–193. 1 indexed citations
12.
Iommelli, Francesca, et al.. (2019). Preclinical Imaging in Targeted Cancer Therapies. Seminars in Nuclear Medicine. 49(5). 369–381. 1 indexed citations
13.
Iommelli, Francesca, Viviana De Rosa, M. Monti, et al.. (2018). Inositol Trisphosphate Receptor Type 3-mediated Enhancement of EGFR and MET Cotargeting Efficacy in Non–Small Cell Lung Cancer Detected by 18F-fluorothymidine. Clinical Cancer Research. 24(13). 3126–3136. 17 indexed citations
14.
Monti, M., Francesca Iommelli, Viviana De Rosa, et al.. (2017). Integrin-dependent cell adhesion to neutrophil extracellular traps through engagement of fibronectin in neutrophil-like cells. PLoS ONE. 12(2). e0171362–e0171362. 47 indexed citations
15.
16.
Iommelli, Francesca, Viviana De Rosa, Rosa Fonti, & Silvana Del Vecchio. (2014). Molecular imaging for detection of sensitivity and resistance to EGFR tyrosine kinase inhibitors in non-small cell lung cancer. Clinical and Translational Imaging. 2(1). 43–53. 3 indexed citations
17.
Iommelli, Francesca, Viviana De Rosa, Sara Gargiulo, et al.. (2014). Monitoring Reversal of MET-Mediated Resistance to EGFR Tyrosine Kinase Inhibitors in Non–Small Cell Lung Cancer Using 3′-Deoxy-3′-[18F]-Fluorothymidine Positron Emission Tomography. Clinical Cancer Research. 20(18). 4806–4815. 23 indexed citations
18.
Zannetti, Antonella, Francesca Iommelli, A. Speranza, Marco Salvatore, & Silvana Del Vecchio. (2012). 3′-Deoxy-3′-18F-Fluorothymidine PET/CT to Guide Therapy with Epidermal Growth Factor Receptor Antagonists and Bcl-xL Inhibitors in Non–Small Cell Lung Cancer. Journal of Nuclear Medicine. 53(3). 443–450. 28 indexed citations
19.
Vecchio, Silvana Del, et al.. (2010). Molecular imaging of tumor microenvironment: challenges and perspectives.. PubMed. 54(3). 249–58. 3 indexed citations
20.
Gatto, Annarita Del, Laura Zaccaro, Paolo Grieco, et al.. (2006). Novel and Selective αvβ3 Receptor Peptide Antagonist:  Design, Synthesis, and Biological Behavior. Journal of Medicinal Chemistry. 49(11). 3416–3420. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pranshu Sahgal Breakdown of academic impact, for papers by Aaron M. LeBeau Breakdown of academic impact, for papers by Steven King Breakdown of academic impact, for papers by Kerstin Schlüter Breakdown of academic impact, for papers by Carmine Fedele Breakdown of academic impact, for papers by Heike Zieher Breakdown of academic impact, for papers by Jun Niu Breakdown of academic impact, for papers by Miran Rada Breakdown of academic impact, for papers by Robert Seed Breakdown of academic impact, for papers by Gian Carlo Alghisi
Rankless by CCL
2026